Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Barr

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Acta Haematologica|August 27, 2024
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell TransplantationGabriela Sanchez-Petitto, Olga Goloubeva, James Childress, et al.
Schizophrenia Bulletin|June 15, 2025
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine UtilizationDeanna L Kelly, Jared Hunt, Gopal Vyas, et al.
Schizophrenia Research|August 26, 2023
Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trialDeanna L Kelly, Matthew Glassman, Ikwunga Wonodi, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Acta Haematologica|August 27, 2024
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell TransplantationGabriela Sanchez-Petitto, Olga Goloubeva, James Childress, et al.
Schizophrenia Bulletin|June 15, 2025
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine UtilizationDeanna L Kelly, Jared Hunt, Gopal Vyas, et al.
Schizophrenia Research|August 26, 2023
Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trialDeanna L Kelly, Matthew Glassman, Ikwunga Wonodi, et al.
Pageof 3